Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

IRIS Clothings Ltd

NSE: IRISDOREME · Textiles Apparels & Accessories · 28 announcements

IRIS Clothings Ltd news stories on ALFA NewsRead the news →
Share price
₹58.52
Market cap
₹1,114 Cr
Revenue (annual)
₹190.9 Cr
Net profit (annual)
₹16.19 Cr
P/E (TTM)
63.4×Sector 52.0×
Promoter holding
58.79%-2.38% QoQ
FII holding
0.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:56 IST NSE
Business Update

IRIS Clothings Business Update

Iris Clothings showcased its Doreme kidswear brand at the Saudi Fashion & Tex Expo. The company aims to explore distribution partnerships across the Middle East and Africa.

19:26 IST NSE
Annual General Meeting

IRIS Clothings Annual General Meeting

Iris Clothings Limited successfully conducted its 15th Annual General Meeting on September 21, 2026, transacting ordinary business including adoption of financial statements and director reappointments.

10:12 IST NSE
Partnership

IRIS Clothings Partnership

Iris Clothings partnered with Amazon to list Doreme products on its e-commerce platform. The tie-up expands digital reach with no stated contract value.

From
Amazon
11:58 IST NSE
Capital Structure Change

IRIS Clothings Capital Structure Change

Iris Clothings Limited has allotted 77,08,183 equity shares on a preferential basis at Rs.41.67 per share. The total transaction value aggregates to Rs.32.12 Crore.

Value
₹32.12 Cr
14:20 IST NSE
Annual General Meeting

IRIS Clothings Annual General Meeting

Iris Clothings Limited has scheduled its 15th Annual General Meeting for September 21, 2026. The meeting will be held virtually to transact ordinary business items.

17:02 IST NSE
Capital Structure Change

IRIS Clothings Capital Structure Change

Iris Clothings received NSE in-principle approval to issue 77,08,183 equity shares on a preferential basis, raising ₹32.12 Crore. This facilitates the planned capital infusion.

Value
₹32.12 Cr